These data suggest that an activated PLOD3-STAT3 signaling pathway is correlated with a poor prognosis in lung cancer patients, and pS-STAT3 plays a major role in comparison with pY-STAT3 in regulating PLOD3 during metastasis. The gene discussed is STAT3; the disease is lung cancer.